MINOXIDIL 7% / NIACINAMIDE 4% S- minoxidil 7% / niacinamide 4% solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

MINOXIDIL (UNII: 5965120SH1) (MINOXIDIL - UNII:5965120SH1), NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)

Available from:

Sincerus Florida, LLC

Administration route:

TOPICAL

Prescription type:

PRESCRIPTION DRUG

Authorization status:

unapproved drug other

Summary of Product characteristics

MINOXIDIL 7% / NIACINAMIDE 4% S- MINOXIDIL 7% / NIACINAMIDE 4%
SOLUTION
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
MINOXIDIL 7% / NIACINAMIDE 4%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC. ADVERSE REACTIONS
ACTIVE, INACTIVE
NDC 72934-4147-8. MINOXIDIL 7% / NIACINAMIDE 4%. SOLUTION 60 GM
MINOXIDIL 7% / NIACINAMIDE 4% S
minoxidil 7% / niacinamide 4 % solution
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-4147
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
MINO XIDIL (UNII: 59 6 5120 SH1) (MINOXIDIL - UNII:59 6 5120 SH1)
MINOXIDIL
7 g in 10 0 g
NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4)
NIACINAMIDE
4 g in 10 0 g
PRODUCT CHARACTERISTICS
COLOR
white (Clear so lutio n)
S CORE
Sincerus Florida, LLC
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:729 34-4147-
8
6 0 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/10 /20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/10 /20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-4147)
Revised: 5/2019